Contact this trialFirst, we need to learn more about you.
Radiation Therapy
Hypo-fractionated vs Standard IMRT with Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Kansas City, Missouri
This trial is testing whether a new radiation treatment plan, combined with two cancer drugs and an immunotherapy drug, can help improve cancer control in the body compared to the standard radiation treatment plan.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service